{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:00:19Z","timestamp":1794650419571,"version":"4.9.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"4","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA225231"],"award-info":[{"award-number":["R01CA225231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA260711"],"award-info":[{"award-number":["R01CA260711"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA271331"],"award-info":[{"award-number":["R01CA271331"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Leukemia and Lymphoma Society","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Leukemia and Lymphoma Society","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"crossref","award":["AACR-MPM grant"],"award-info":[{"award-number":["AACR-MPM grant"]}],"id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012636","name":"New York State Stem Cell Science","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100012636","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The reprogramming of human acute myeloid leukemia (AML) cells into induced pluripotent stem cell (iPSC) lines could provide new faithful genetic models of AML, but is currently hindered by low success rates and uncertainty about whether iPSC-derived cells resemble their primary counterparts. Here we developed a reprogramming method tailored to cancer cells, with which we generated iPSCs from 15 patients representing all major genetic groups of AML. These AML-iPSCs retain genetic fidelity and produce transplantable hematopoietic cells with hallmark phenotypic leukemic features. Critically, single-cell transcriptomics reveal that, upon xenotransplantation, iPSC-derived leukemias faithfully mimic the primary patient-matched xenografts. Transplantation of iPSC-derived leukemias capturing a clone and subclone from the same patient allowed us to isolate the contribution of a FLT3-ITD mutation to the AML phenotype. The results and resources reported here can transform basic and preclinical cancer research of AML and other human cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We report the generation of patient-derived iPSC models of all major genetic groups of human AML. These exhibit phenotypic hallmarks of AML in vitro and in vivo, inform the clonal hierarchy and clonal dynamics of human AML, and exhibit striking similarity to patient-matched primary leukemias upon xenotransplantation.<\/jats:p>\n                    <jats:p>See related commentary by Doulatov, p. 252.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 247<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-22-0167","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T14:45:54Z","timestamp":1681742754000},"page":"318-335","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9148-6015","authenticated-orcid":false,"given":"Andriana G.","family":"Kotini","sequence":"first","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"4Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-1045","authenticated-orcid":false,"given":"Saul","family":"Carcamo","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"5Bioinformatics for Next-Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5849-8011","authenticated-orcid":false,"given":"Nataly","family":"Cruz-Rodriguez","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"4Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3416-1635","authenticated-orcid":false,"given":"Malgorzata","family":"Olszewska","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"4Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-7712","authenticated-orcid":false,"given":"Tiansu","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"4Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-0407","authenticated-orcid":false,"given":"Deniz","family":"Demircioglu","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"5Bioinformatics for Next-Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-2764","authenticated-orcid":false,"given":"Chan-Jung","family":"Chang","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"4Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2057-7187","authenticated-orcid":false,"given":"Elsa","family":"Bernard","sequence":"additional","affiliation":[{"name":"6Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-7272","authenticated-orcid":false,"given":"Mark P.","family":"Chao","sequence":"additional","affiliation":[{"name":"7Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California."},{"name":"8Cancer Institute, Stanford University School of Medicine, Stanford, California."},{"name":"9Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5814-0984","authenticated-orcid":false,"given":"Ravindra","family":"Majeti","sequence":"additional","affiliation":[{"name":"7Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California."},{"name":"8Cancer Institute, Stanford University School of Medicine, Stanford, California."},{"name":"9Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-967X","authenticated-orcid":false,"given":"Hanzhi","family":"Luo","sequence":"additional","affiliation":[{"name":"10Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"11Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"12Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"13Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1165-6991","authenticated-orcid":false,"given":"Michael G.","family":"Kharas","sequence":"additional","affiliation":[{"name":"10Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"11Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"12Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"13Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-1636","authenticated-orcid":false,"given":"Dan","family":"Hasson","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"5Bioinformatics for Next-Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7002-417X","authenticated-orcid":false,"given":"Eirini P.","family":"Papapetrou","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"4Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2025112416574506000_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2025112416574506000_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrg3764","article-title":"Investigating human disease using stem cell models","volume":"15","author":"Sterneckert","year":"2014","journal-title":"Nat Rev Genet"},{"key":"2025112416574506000_bib3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nm.4238","article-title":"Patient-derived induced pluripotent stem cells in cancer research and precision oncology","volume":"22","author":"Papapetrou","year":"2016","journal-title":"Nat Med"},{"key":"2025112416574506000_bib4","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.celrep.2013.05.036","article-title":"An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression","volume":"3","author":"Kim","year":"2013","journal-title":"Cell Rep"},{"key":"2025112416574506000_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.stemcr.2016.08.013","article-title":"Development refractoriness of MLL-rearranged human B cell acute leukemias to reprogramming into pluripotency","volume":"7","author":"Munoz-Lopez","year":"2016","journal-title":"Stem Cell Reports"},{"key":"2025112416574506000_bib6","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/stem.2655","article-title":"Brief report: human acute myeloid leukemia reprogramming to pluripotency is a rare event and selects for patient hematopoietic cells devoid of leukemic mutations","volume":"35","author":"Lee","year":"2017","journal-title":"Stem Cells"},{"key":"2025112416574506000_bib7","doi-asserted-by":"crossref","first-page":"a034868","DOI":"10.1101\/cshperspect.a034868","article-title":"Modeling leukemia with human induced pluripotent stem cells","volume":"9","author":"Papapetrou","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025112416574506000_bib8","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"N Engl J Med"},{"key":"2025112416574506000_bib9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ncb3419","article-title":"Progress towards generation of human haematopoietic stem cells","volume":"18","author":"Wahlster","year":"2016","journal-title":"Nat Cell Biol"},{"key":"2025112416574506000_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2016.11.018","article-title":"Human AML-iPSCs reacquire leukemic properties after differentiation and model clonal variation of disease","volume":"20","author":"Chao","year":"2017","journal-title":"Cell Stem Cell"},{"key":"2025112416574506000_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","article-title":"Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia","volume":"20","author":"Kotini","year":"2017","journal-title":"Cell Stem Cell"},{"key":"2025112416574506000_bib12","doi-asserted-by":"crossref","first-page":"107688","DOI":"10.1016\/j.celrep.2020.107688","article-title":"Acute myeloid leukemia iPSCs reveal a role for RUNX1 in the maintenance of human leukemia stem cells","volume":"31","author":"Wesely","year":"2020","journal-title":"Cell Rep"},{"key":"2025112416574506000_bib13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nature08285","article-title":"Immortalization eliminates a roadblock during cellular reprogramming into iPS cells","volume":"460","author":"Utikal","year":"2009","journal-title":"Nature"},{"key":"2025112416574506000_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08287","article-title":"A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity","volume":"460","author":"Marion","year":"2009","journal-title":"Nature"},{"key":"2025112416574506000_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nature08290","article-title":"The Ink4\/Arf locus is a barrier for iPS cell reprogramming","volume":"460","author":"Li","year":"2009","journal-title":"Nature"},{"key":"2025112416574506000_bib16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nature08311","article-title":"Linking the p53 tumour suppressor pathway to somatic cell reprogramming","volume":"460","author":"Kawamura","year":"2009","journal-title":"Nature"},{"key":"2025112416574506000_bib17","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nature08235","article-title":"Suppression of induced pluripotent stem cell generation by the p53-p21 pathway","volume":"460","author":"Hong","year":"2009","journal-title":"Nature"},{"key":"2025112416574506000_bib18","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1101\/gad.1811609","article-title":"Senescence impairs successful reprogramming to pluripotent stem cells","volume":"23","author":"Banito","year":"2009","journal-title":"Genes Dev"},{"key":"2025112416574506000_bib19","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1182\/blood-2012-02-408674","article-title":"Overcoming reprogramming resistance of Fanconi anemia cells","volume":"119","author":"Muller","year":"2012","journal-title":"Blood"},{"key":"2025112416574506000_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature08129","article-title":"Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells","volume":"460","author":"Raya","year":"2009","journal-title":"Nature"},{"key":"2025112416574506000_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.1717","article-title":"Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells","volume":"29","author":"Papapetrou","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2025112416574506000_bib22","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/nprot.2011.362","article-title":"Derivation of genetically modified human pluripotent stem cells with integrated transgenes at unique mapped genomic sites","volume":"6","author":"Papapetrou","year":"2011","journal-title":"Nat Protoc"},{"key":"2025112416574506000_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.2018884338","article-title":"Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes","volume":"134","author":"Hsu","year":"2019","journal-title":"Blood"},{"key":"2025112416574506000_bib24","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"2025112416574506000_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/2643-3230.BCD-21-0155","article-title":"Convergent clonal evolution of signaling gene mutations is a hallmark of myelodysplastic syndrome progression","volume":"3","author":"Menssen","year":"2022","journal-title":"Blood Cancer Discov"},{"key":"2025112416574506000_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"key":"2025112416574506000_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gde.2018.06.002","article-title":"Cellular trajectories and molecular mechanisms of iPSC reprogramming","volume":"52","author":"Apostolou","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"2025112416574506000_bib28","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.stem.2021.01.011","article-title":"Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"2025112416574506000_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2014.01.031","article-title":"Functional heterogeneity of genetically defined subclones in acute myeloid leukemia","volume":"25","author":"Klco","year":"2014","journal-title":"Cancer Cell"},{"key":"2025112416574506000_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"2025112416574506000_bib31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"2025112416574506000_bib32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41586-022-04571-x","article-title":"Mapping human haematopoietic stem cells from haemogenic endothelium to birth","volume":"604","author":"Calvanese","year":"2022","journal-title":"Nature"},{"key":"2025112416574506000_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"2025112416574506000_bib34","doi-asserted-by":"crossref","first-page":"149ra18","DOI":"10.1126\/scitranslmed.3004315","article-title":"Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia","volume":"4","author":"Jan","year":"2012","journal-title":"Sci Transl Med"},{"key":"2025112416574506000_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"key":"2025112416574506000_bib36","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.stemcr.2018.03.020","article-title":"Dissecting the contributions of cooperating gene mutations to cancer phenotypes and drug responses with patient-derived iPSCs","volume":"10","author":"Chang","year":"2018","journal-title":"Stem Cell Reports"},{"key":"2025112416574506000_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nbt.3178","article-title":"Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells","volume":"33","author":"Kotini","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2025112416574506000_bib38","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/bloodadvances.2021006325","article-title":"Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs","volume":"6","author":"Asimomitis","year":"2022","journal-title":"Blood Adv"},{"key":"2025112416574506000_bib39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.celrep.2018.12.098","article-title":"Chromatin-based classification of genetically heterogeneous AMLs into two distinct subtypes with diverse stemness phenotypes","volume":"26","author":"Yi","year":"2019","journal-title":"Cell Rep"},{"key":"2025112416574506000_bib40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat Med"},{"key":"2025112416574506000_bib41","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","article-title":"Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML","volume":"113","author":"Zeng","year":"2009","journal-title":"Blood."},{"key":"2025112416574506000_bib42","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"key":"2025112416574506000_bib43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112416574506000_bib44","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"2025112416574506000_bib45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2025112416574506000_bib46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/bioinformatics\/btv715","article-title":"destiny: diffusion maps for large-scale single-cell data in R","volume":"32","author":"Angerer","year":"2016","journal-title":"Bioinformatics"},{"key":"2025112416574506000_bib47","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"2025112416574506000_bib48","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nmeth.3971","article-title":"Diffusion pseudotime robustly reconstructs lineage branching","volume":"13","author":"Haghverdi","year":"2016","journal-title":"Nat Methods"},{"key":"2025112416574506000_bib49","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1038\/s41467-020-19894-4","article-title":"muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data","volume":"11","author":"Crowell","year":"2020","journal-title":"Nat Commun"},{"key":"2025112416574506000_bib50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-22-0167\/3323856\/bcd-22-0167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/4\/4\/318\/3343519\/318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/4\/4\/318\/3343519\/318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:57:58Z","timestamp":1764021478000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/4\/4\/318\/727506\/Patient-Derived-iPSCs-Faithfully-Represent-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,17]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-22-0167","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.6603193","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22645267.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6603193.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6603193.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.23627663","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22645267","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22645264.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.23627663.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22645264","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.23627666.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.23627666","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.23627666","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.23627666.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.23627663","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30698638","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30698635","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.23627663.v1","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]}}}